Vnitr Lek 2018, 64(9):847-851 | DOI: 10.36290/vnl.2018.116

Diagnosis of heart failure: the new classification of heart failure

Barbora Nussbaumerová*, Hana Rosolová
Centrum preventivní kardiologie II. interní kliniky LF UK a FN Plzeň

Heart failure (HF) is a clinical syndrome characterized by typical symptoms (e.g. breathlessness, ankle swelling and fatigue) that may be accompanied by signs (e.g. elevated jugular venous pressure, pulmonary crackles and periphe-ral oedema) caused by a structural and/or functional cardiac abnormality, resulting in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress. Natriuretic peptides have a significant negative predictive value for excluding of heart failure. Echocardiography is the most important imaging method in heart failure. The new classification distinguishes HF by left ventricule ejection fraction (LV EF) into 3 groups: HF with preserved EF - HFpEF with LV EF ≥ 50 %, mid-range EF - HFmrEF with LV EF 40-49 % and HF with reduced EF - HFrEF with LV EF < 40 %. A quantity of examination methods is available in heart failure diagnosis and treatment.

Keywords: classification; diagnosis; echocardiography; heart failure; natriuretic peptides

Received: July 30, 2018; Accepted: August 13, 2018; Published: September 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nussbaumerová B, Rosolová H. Diagnosis of heart failure: the new classification of heart failure. Vnitr Lek. 2018;64(9):847-851. doi: 10.36290/vnl.2018.116.
Download citation

References

  1. Špinar J, Hradec J, Špinarová L et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(5): e530-e568. Dostupné z DOI: <https://doi.org/10.1016/j.crvasa.2016.09.004>. Go to original source...
  2. Ponikowski PA, Voors A, Anker SD et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37(27): 2129-2200. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw128>. Erratum in Erratum. [Eur Heart J. 2018]. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.